| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $69.6M | -22.1% |
| SG&A Expense | $71.8M | +334.3% |
| Operating Income | -$141.4M | -33.5% |
| Income Tax | $0 | — |
| Net Income | -$24.3M | +75.0% |
| EPS (Basic) | -$0.53 | +77.2% |
| EPS (Diluted) | -$1.46 | +37.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $128.6M | +6.1% |
| Current Assets | $136.5M | +5.3% |
| Total Assets | $157.5M | +3.9% |
| Current Liabilities | $11.8M | -17.2% |
| Total Liabilities | $11.8M | -16.7% |
| Stockholders' Equity | $145.7M | +6.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$116.9M | -42.6% |
| Capital Expenditures | $103K | -75.1% |
| Investing Cash Flow | -$103K | +75.1% |
| Financing Cash Flow | $124.5M | +4762.1% |
| Free Cash Flow | -$117.0M | -42.0% |